William G. Rice - 19 Sep 2022 Form 4 Insider Report for Aptose Biosciences Inc. (APTOF)

Role
Chair, President & CEO, Director
Signature
/s/ Leslie Auld as attorney-in-fact for William G. Rice
Issuer symbol
APTOF
Transactions as of
19 Sep 2022
Net transactions value
+$6,834
Form type
4
Filing time
21 Sep 2022, 18:07:23 UTC
Previous filing
07 Jul 2022
Next filing
23 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APTO Common Shares Purchase $6,834 +10,000 +2.8% $0.6834* 363,252 19 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchase price reported in Column 4 represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6834 to $0.6835, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above.

Remarks:

Exhibit 24.2 Power of Attorney